Canada
· Delayed Price · Currency is CAD DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of CAD 24.26 million. The enterprise value is 26.84 million.
| Market Cap | 24.26M |
| Enterprise Value | 26.84M |
Important Dates
The next estimated earnings date is Thursday, November 28, 2024.
| Earnings Date | Nov 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DIAGNOS has 95.15 million shares outstanding. The number of shares has increased by 6.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 95.15M |
| Shares Change (YoY) | +6.39% |
| Shares Change (QoQ) | +4.05% |
| Owned by Insiders (%) | 5.82% |
| Owned by Institutions (%) | n/a |
| Float | 89.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 116.23 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.70 |
| EV / Sales | 164.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.68 |
Financial Position
The company has a current ratio of 0.39
| Current Ratio | 0.39 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.40 |
| Interest Coverage | -4.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -134.33% |
| Return on Capital (ROIC) | -204.96% |
| Revenue Per Employee | 7,433 |
| Profits Per Employee | -140,230 |
| Employee Count | 22 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.71% in the last 52 weeks. The beta is -0.46, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.46 |
| 52-Week Price Change | -35.71% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 26.22 |
| Average Volume (20 Days) | 103,633 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of CAD 163,525 and -3.09 million in losses. Loss per share was -0.04.
| Revenue | 163,525 |
| Gross Profit | -753,808 |
| Operating Income | -2.54M |
| Pretax Income | -3.09M |
| Net Income | -3.09M |
| EBITDA | -2.52M |
| EBIT | -2.54M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 637,734 in cash and 3.22 million in debt, giving a net cash position of -2.58 million or -0.03 per share.
| Cash & Cash Equivalents | 637,734 |
| Total Debt | 3.22M |
| Net Cash | -2.58M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -2.44M |
| Book Value Per Share | -0.03 |
| Working Capital | -1.36M |
Cash Flow
In the last 12 months, operating cash flow was -2.29 million and capital expenditures -9,454, giving a free cash flow of -2.30 million.
| Operating Cash Flow | -2.29M |
| Capital Expenditures | -9,454 |
| Free Cash Flow | -2.30M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,556.00% |
| Pretax Margin | -1,886.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,405.55% |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.39% |
| Shareholder Yield | -6.39% |
| Earnings Yield | -16.23% |
| FCF Yield | -9.47% |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -69.2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -69.2 |
| Piotroski F-Score | n/a |